Synapse Open Synapse
Science

Why pharma firms are betting billions on psychedelic drugs despite setbacks

Nature News · · 5 min read

Regulatory pushback stalled the field. But researchers are optimistic about mind-altering drugs as potential treatments for depression and mood disorders.

Latest from Nature News